Compound
    Moderate Evidence

    Melatonin

    N-acetyl-5-methoxytryptamine

    TL;DR

    Melatonin is a circadian timing signal, not a sedative. Low doses of 0.5-1 mg taken several hours before bed shift your body clock; the 5-10 mg doses sold in shops are supraphysiological and often no more effective for sleep onset.

    Ideal For

    • Jet lag, particularly eastward travel
    • Delayed sleep phase syndrome and night owls trying to shift earlier
    • Shift workers adapting to rotating schedules
    • Older adults, whose endogenous melatonin production declines
    • Blind people with non-24-hour sleep-wake disorder

    Avoid If

    • You are pregnant or breastfeeding — safety data is inadequate
    • You take warfarin or other anticoagulants without medical review
    • You have an autoimmune condition, given immunomodulatory effects
    • You need to drive or operate machinery within several hours of the dose
    • You are giving it to a child without paediatric advice

    Frequently Asked Questions

    Overview

    Melatonin is a hormone produced by the pineal gland in response to darkness. Its role is to signal biological night — telling the suprachiasmatic nucleus, the body's master clock, what time it is. It is not a sedative and does not work like one.

    This distinction explains most of the confusion around it. Meta-analyses of melatonin for insomnia show a modest effect: sleep onset shortened by roughly seven to twelve minutes and total sleep time increased by around eight to twenty minutes. Those are real but small effects. Where melatonin genuinely excels is circadian misalignment — jet lag, delayed sleep phase disorder, shift work, and non-24-hour sleep-wake disorder in blind people. Here the effects are substantial, and the timing of the dose matters more than the size.

    The dose-response relationship is counterintuitive. Physiological nocturnal melatonin levels correspond to roughly 0.1-0.3 mg. Doses of 5-10 mg produce blood levels many times higher than the body ever generates, which does not improve efficacy and can prolong the signal into the morning, producing grogginess and, paradoxically, further circadian delay.

    Timing follows the phase response curve. Taken in the early evening, several hours before habitual sleep, melatonin advances the clock, making you sleepy earlier. Taken in the early morning hours it delays the clock. This is why someone with delayed sleep phase should take a small dose around five hours before their target bedtime rather than at bedtime itself.

    Product quality is a genuine problem. Analyses of commercial melatonin have found actual content ranging from a small fraction to several times the label claim, with serotonin contamination detected in a minority of products. Choose third-party tested brands.

    How It Works

    • Binds MT1 and MT2 receptors in the suprachiasmatic nucleus, the master circadian clock
    • MT1 activation reduces the alerting signal; MT2 activation shifts circadian phase
    • Signals biological darkness, entraining the sleep-wake cycle to the light-dark cycle
    • Lowers core body temperature slightly, facilitating sleep onset
    • Has antioxidant activity, though relevance at supplemental doses is unclear

    Quick Facts

    • It is a timing signal, not a sedative
    • Physiological levels correspond to roughly 0.1-0.3 mg, not the 5-10 mg commonly sold
    • Meta-analyses show sleep onset shortened by only about 7-12 minutes in insomnia
    • Timing matters more than dose for circadian problems
    • Commercial products frequently deviate substantially from label content

    Benefits & Outcomes

    Dream Quality Enhancement

    Sleep
    Mixed evidence
    Limited
    Effectiveness 2/5

    Frequently increases dream vividness anecdotally; the trial evidence is about circadian timing, not dream quality.

    Sleep Apnea Symptom Relief

    Sleep
    Insufficient evidence
    Limited

    Melatonin may improve sleep quality alongside treatment but does nothing for airway collapse.

    Sleep Maintenance

    Sleep
    Insufficient evidence
    Moderate Evidence

    Melatonin helps sleep onset and circadian timing far more than it helps staying asleep.

    Shift Work Adaptation

    Sleep
    Strong yes
    Strong Evidence

    Melatonin taken before daytime sleep is the best-evidenced supplement for shift workers.

    Night Sweats Reduction

    Sleep
    Insufficient evidence
    Limited
    Effectiveness 2/5

    Improves sleep architecture disrupted by sweats; no direct thermoregulatory effect.

    Jet Lag Recovery

    Sleep
    Strong yes
    Strong Evidence

    Melatonin is the best-supported supplement for jet lag, cutting adjustment time when timed to destination bedtime.

    Deep Sleep Enhancement

    Sleep
    Mixed evidence
    Moderate Evidence
    Effectiveness 2/5

    Best for onset and circadian timing; not a deep-sleep enhancer per se.

    Faster Sleep Onset

    Sleep
    Strong yes
    Moderate Evidence

    Melatonin shortens sleep latency by roughly 7-12 minutes on average - consistent and statistically robust, but a modest real-world change.

    Circadian Rhythm

    Sleep
    Strong yes
    Strong Evidence

    Melatonin is the only supplement with strong evidence for shifting the circadian clock — when timed correctly.

    Improved Sleep Quality

    Sleep
    Strong yes
    Strong Evidence
    Effectiveness 4/5

    First-line for circadian issues, jet lag and delayed sleep phase; less effective for staying asleep.

    Growth Hormone Support

    Hormonal
    Mixed evidence
    Limited
    Effectiveness 3/5

    Indirect but plausible: better deep sleep means better natural GH release.

    Antioxidant Protection

    Longevity
    Mixed evidence
    Moderate Evidence
    Effectiveness 2/5

    Take it for sleep timing, not as an antioxidant strategy.

    Health Concerns Addressed

    Traumatic Brain Injury

    condition
    Likely effective
    Moderate Evidence
    Effectiveness 4/5

    Likely effective for the sleep disturbance that follows traumatic brain injury, which indirectly supports recovery.

    Insomnia

    condition
    Mixed evidence
    Moderate Evidence
    Effectiveness 3/5

    Cheap and safe to try at a low dose, but do not expect much. If insomnia is persistent, CBT-I is the intervention with the real evidence.

    Vivid Dreams

    symptom
    Mixed evidence
    Effectiveness 2/5

    This pairing is mostly cautionary: melatonin is a recognized cause of vivid dreams and nightmares in some users, particularly at higher doses. If vivid dreams started with melatonin, lowering the dose or stopping is the fix.

    Early Morning Waking

    symptom
    Mixed evidence
    Effectiveness 2/5

    A phase-shifting hormone, not a sleep drug — and evening dosing pushes an already-advanced clock further in the wrong direction. Right tool for the wrong problem in most early-waking cases.

    Nightmares

    symptom
    Insufficient evidence
    Moderate Evidence
    Effectiveness 2/5

    Melatonin is more likely suspect than solution for nightmares — vivid dreams and nightmares are recognised side effects, particularly above 3-5 mg, because it increases REM sleep where nightmares occur.

    Sleep Paralysis

    symptom
    Insufficient evidence
    Effectiveness 2/5

    No supplement, including melatonin, has good evidence for sleep paralysis — the proven fixes are regular sleep and position changes.

    Frequent Night Waking

    symptom
    Mixed evidence
    Moderate Evidence
    Effectiveness 2/5

    Modest maintenance benefit with prolonged-release in older adults; weak for general night waking.

    Heartburn & Acid Reflux

    symptom
    Mixed evidence
    Limited
    Effectiveness 2/5

    Small trials suggest melatonin improves lower esophageal sphincter pressure and heartburn scores, but the studies are few and mostly from a single research group.

    Poor Sleep Quality

    symptom
    Likely effective
    Moderate Evidence
    Effectiveness 3/5

    Worth trying at 0.5-1 mg, especially if your body clock runs late. Do not expect sedative-strength effects.

    Supporting Research
    55 studies

    The Effect of Magnesium Supplementation on Primary Insomnia in Elderly: A Double-Blind Placebo-Controlled Clinical Trial

    Score: 7/10
    2012
    rct
    n=46

    Abbasi B, Kimiagar M, Sadeghniiat K +3 more

    Magnesium supplementation significantly improved PSQI scores (p<0.05) Significant increase in sleep time by 42 minutes (p<0.001) Improved sleep efficiency from 74% to 85% (p<0.001) Reduced early morning awakening frequency (p<0.01) Increased serum melatonin concentration (p<0.05) Decreased serum cortisol levels (p<0.05) Reduced sleep onset latency by 17 minutes

    View source

    The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial

    Score: 7/10
    2012
    rct
    n=46

    Abbasi B, Kimiagar M, Sadeghniiat K +3 more

    Magnesium supplementation significantly improved PSQI scores (p<0.05) Significant increase in sleep time by 42 minutes (p<0.001) Improved sleep efficiency from 74% to 85% (p<0.001) Reduced early morning awakening frequency (p<0.01) Increased serum melatonin concentration (p<0.05) Decreased serum cortisol levels (p<0.05) Reduced sleep onset latency by 17 minutes

    View source

    An investigation into an evening intake of a saffron extract (affron) on sleep quality, cortisol, and melatonin concentrations in adults with poor sleep: a randomised, double-blind, placebo-controlled, multi-dose study

    Score: 7/10
    2021
    rct
    n=120

    Lopresti AL, et al.

    These results provide further validation of the sleep-enhancing effects of 28-days of saffron supplementation in adults with unsatisfactory sleep.

    View source

    The effect of melatonin, magnesium, and zinc on primary insomnia in long-term care facility residents in Italy: a double-blind, placebo-controlled clinical trial

    Score: 7/10
    2011
    rct
    n=43

    Rondanelli M, et al.

    The administration of nightly melatonin, magnesium, and zinc appears to improve the quality of sleep and the quality of life in long-term care facility residents with primary insomnia.

    View source

    Magnesium supplementation and sleep quality in older adults: a double-blind placebo-controlled trial

    Score: 6/10
    2012
    rct
    n=46

    Abbasi B, Kimiagar M, Sadeghniiat K +3 more

    Magnesium increased serum melatonin and improved sleep efficiency and sleep onset latency versus placebo.

    View source

    Effects of tryptophan-enriched cereals consumed at breakfast and dinner on sleep, mood and melatonin in elderly people

    Score: 5/10
    2013
    crossover
    n=35

    Bravo R, Matito S, Cubero J

    Tryptophan-enriched cereals increased sleep efficiency, actual sleep time and urinary melatonin while reducing depression and anxiety scores in older adults.

    View source

    The Effect of Magnesium Supplementation on Primary Insomnia in Elderly

    Score: 7/10
    2012
    rct
    n=46

    Abbasi B, Kimiagar M, Sadeghniiat K +1 more

    Magnesium supplementation significantly improved PSQI scores (p<0.05) Significant increase in sleep time by 42 minutes (p<0.001) Improved sleep efficiency from 74% to 85% (p<0.001) Reduced early morning awakening frequency (p<0.01) Increased serum melatonin concentration (p<0.05) Decreased serum cortisol levels (p<0.05) Reduced sleep onset latency by 17 minutes

    View source

    Effects of nocturnal light exposure on melatonin suppression: a systematic review and meta-analysis

    Score: 8/10
    2019
    meta_analysis

    Tahkamo L, Partonen T, Pesonen AK

    Short-wavelength evening light produced substantial dose-dependent suppression of endogenous melatonin secretion.

    View source

    Creatine supplementation, sleep deprivation, cortisol, melatonin and behavior

    Score: 5/10
    2007
    rct

    McMorris T, et al.

    In sleep-deprived participants, creatine supplementation (20 g/day for 7 days) attenuated the decline in performance on complex tasks requiring executive function and reduced the rise in salivary cortisol during 24 hours of sleep deprivation, without altering melatonin rhythm; simple tasks were unaffected.

    View source

    The effect of magnesium supplementation on primary insomnia in elderly: a double-blind placebo-controlled clinical trial

    Score: 5/10
    2012n=46

    Abbasi B, Kimiagar M, Sadeghniiat K +3 more

    Magnesium significantly increased sleep time and sleep efficiency and reduced Insomnia Severity Index scores, sleep onset latency and early morning awakening compared with placebo. Serum renin and melatonin increased and serum cortisol decreased in the magnesium group.

    View source

    Tryptophan and vitamin B6 status in relation to melatonin synthesis: a randomized controlled trial

    Score: 6/10
    2005
    rct
    n=18

    Hudson C, Hudson SP, Hecht T +1 more

    Tryptophan supplementation increased overnight melatonin metabolite excretion and improved sleep continuity.

    View source

    Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders

    Score: 9/10
    2017
    systematic_review

    Auld F, Maschauer EL, Morrison I +2 more

    Melatonin showed the strongest evidence for reducing sleep onset latency in primary insomnia and for circadian rhythm disorders.

    View source

    Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis

    Score: 9/10
    2022
    systematic_review
    n=47950

    De Crescenzo F, et al.

    Melatonin, ramelteon, and non-licensed drugs did not show overall material benefits.

    View source

    Melatonin supplementation and oxidative DNA damage repair capacity among night shift workers: a randomised placebo-controlled trial

    Score: 7/10
    2025
    rct

    Melatonin supplementation improves oxidative DNA damage repair capacity among night shift workers.

    View source

    Effectiveness of ramelteon for insomnia symptoms in older adults with obstructive sleep apnea: a randomized placebo-controlled pilot study

    Score: 5/10
    2010
    rct
    n=21

    Gooneratne NS, Gehrman P, Gurubhagavatula I +1 more

    Ramelteon treatment was associated with a statistically significant difference in sleep onset latency (SOL) as measured by polysomnography of 28.5 min compared to placebo

    View source

    Melatonin for preventing and treating jet lag

    Score: 9/10
    2001
    systematic_review

    Herxheimer A, Petrie KJ

    Melatonin for preventing and treating jet lag

    View source

    Adjuvant use of melatonin for pain management in endometriosis-associated pelvic pain: a randomized double-blinded, placebo-controlled trial

    Score: 8/10
    2023
    rct
    n=40

    Soderman L, Bottiger Y, Edlund M +2 more

    The difference in endometriosis-associated pain between the groups showed to be non-significant statistically as well as clinically

    View source

    Melatonin in autism spectrum disorders: a systematic review and meta-analysis

    Score: 8/10
    2011
    meta_analysis

    Rossignol DA, Frye RE

    Melatonin supplementation in ASD improved sleep duration and sleep onset latency with minimal side effects.

    View source

    Melatonin and delirium in the intensive care units: a systematic review and meta-analysis of randomized controlled trials

    Score: 8/10
    2025
    meta_analysis
    n=2830

    Lakbar I, et al.

    Compared to placebo, melatonin does not reduce delirium incidence in critically ill patients.

    View source

    Melatonin for shift work sleep disorder and circadian adaptation: a Cochrane review

    Score: 8/10
    2014
    systematic_review
    n=718

    Liira J, Verbeek JH, Costa G +4 more

    Melatonin increased sleep length after night shift by around 24 minutes but did not improve sleep onset latency or alertness on shift

    View source

    Efficacy of melatonin for chronic insomnia: Systematic reviews and meta-analyses

    Score: 8/10
    2022
    meta_analysis

    Melatonin produced small improvements in sleep onset latency and sleep quality in chronic insomnia.

    View source

    Is the addition of sublingual melatonin to omeprazole superior to omeprazole alone in the management of gastroesophageal reflux disease symptoms: a clinical trial

    Score: 7/10
    2023
    rct
    n=78

    Malekpour H, Noori A, Abdi S +2 more

    The present study aimed to investigate whether the addition of sublingual melatonin to omeprazole was effective in the treatment of gastro gastroesophageal reflux disease symptoms.

    View source

    Antioxidants for female subfertility

    Score: 9/10
    2020
    systematic_review

    Showell MG, Mackenzie-Proctor R, Jordan V +1 more

    low-quality evidence shows no difference in a lower dose of melatonin being associated with an increased live-birth rate compared with higher-dose melatonin (OR 0.94, 95% CI 0.41 to 2.15; P = 0.89, I2 = 0%; 2 RCTs, 140 women)

    View source

    Sleep Problems and Melatonin Prescription After Concussion Among Youth Athletes

    Score: 6/10
    2021
    cohort
    n=225

    Howell DR

    Melatonin prescription was not associated with faster symptom recovery.

    View source

    Melatonin and agomelatine for preventing seasonal affective disorder

    Score: 8/10
    2019
    systematic_review
    n=150

    Nussbaumer-Streit B, Greenblatt A, Kaminski-Hartenthaler A

    Given the uncertain evidence on agomelatine and the absence of studies on melatonin, no conclusion about efficacy and safety of agomelatine and melatonin for prevention of SAD can currently be drawn.

    View source

    Analgesic and sedative effects of melatonin in temporomandibular disorders: a double-blind, randomized, parallel-group, placebo-controlled study

    Score: 7/10
    2013
    rct
    n=32

    Vidor LP, et al.

    This study provides additional evidence supporting the analgesic effects of melatonin on pain scores and analgesic consumption in patients with mild-to-moderate chronic myofascial TMD pain.

    View source

    Melatonin for delirium prevention in hospitalized patients: a systematic review and meta-analysis

    Score: 7/10
    2021
    meta_analysis
    n=1712

    Khaing K, Nair BR

    Melatonin reduced delirium incidence in medical inpatients but not consistently in surgical populations.

    View source

    Melatonin: can it stop the ringing?

    Score: 6/10
    2011
    crossover

    Melatonin is associated with a statistically significant decrease in tinnitus intensity and improved sleep quality in patients with chronic tinnitus.

    View source

    Melatonin as add-on treatment for epilepsy

    Score: 7/10
    2016
    systematic_review
    n=125

    Brigo F, Igwe SC, Del Felice A

    No conclusions could be drawn regarding the role of melatonin as add-on treatment for epilepsy.

    View source

    Efficacy of melatonin for sleep disturbance in middle-aged primary insomnia: a double-blind, randomised clinical trial

    Score: 6/10
    2020
    rct

    Melatonin improved sleep quality and continuity versus placebo in middle-aged primary insomnia.

    View source

    Ramelteon-induced nightmares: a case report

    Score: 3/10
    2015
    case_study
    n=1

    Shah C, Kablinger A

    Shortly after initiation of ramelteon, he described vivid nightmares leading to discontinuation of ramelteon. The nightmares ameliorated with ramelteon discontinuation.

    View source

    The efficacy and safety of exogenous melatonin for primary sleep disorders: a meta-analysis

    Score: 9/10
    2005
    meta_analysis

    Buscemi N, Vandermeer B, Hooton N +6 more

    Melatonin reduced sleep onset latency by a small but statistically significant amount, with no significant effect on sleep efficiency or total sleep time.

    View source

    Effect of tart cherry juice (Prunus cerasus) on melatonin levels and enhanced sleep quality

    Score: 6/10
    2012
    crossover
    n=20

    Howatson G, et al.

    consumption of a tart cherry juice concentrate provides an increase in exogenous melatonin that is beneficial in improving sleep duration and quality

    View source

    Pharmacotherapies for sleep disturbances in dementia

    Score: 9/10
    2016
    systematic_review
    n=222

    McCleery J, et al.

    From single studies, we found no difference between melatonin and placebo groups for sleep efficiency, time awake after sleep onset, or number of night-time awakenings.

    View source

    Effect of melatonin on incidence of delirium among patients with hip fracture: a multicentre, double-blind randomized controlled trial

    Score: 8/10
    2014
    rct
    n=452

    de Jonghe A, van Munster BC, Goslings JC

    Melatonin did not reduce delirium incidence compared with placebo.

    View source

    Jet lag

    Score: 7/10
    2014
    systematic_review

    Herxheimer A

    Melatonin taken close to target bedtime reduced subjective jet lag after eastward and westward flights

    View source

    Regression of gastroesophageal reflux disease symptoms using dietary supplementation with melatonin, vitamins and aminoacids: comparison with omeprazole

    Score: 5/10
    2006
    rct
    n=351

    Pereira RS

    Melatonin has known inhibitory activities on gastric acid secretion and nitric oxide biosynthesis.

    View source

    Pharmacological treatments of REM sleep behaviour disorder in synucleinopathies: a systematic review of effectiveness and safety

    Score: 7/10
    2026
    systematic_review

    Sleep Medicine review authors

    Clonazepam and melatonin remain the principal treatments in practice, but evidence was limited and inconsistent.

    View source

    The Effects of Pharmacological Treatment of Nightmares: A Systematic Literature Review and Meta-Analysis of Placebo-Controlled, Randomized Clinical Trials

    Score: 8/10
    2022
    meta_analysis

    Pharmacological treatments for nightmares, including melatonergic agents, produced only small effects versus placebo.

    View source

    Melatonin for sleep disorders

    Score: 8/10
    2013
    meta_analysis
    n=1683

    Ferracioli-Oda, E., Qawasmi, A.

    Melatonin reduced sleep onset latency and increased total sleep time and sleep quality across primary sleep disorders.

    View source

    Regression of gastroesophageal reflux disease symptoms using dietary supplementation with melatonin, vitamins and aminoacids: comparison with omeprazole

    Score: 5/10
    2006
    rct
    n=351

    Pereira RS

    Complete regression of GERD symptoms occurred in 100% of patients that used the dietary supplementation, and in 65.7% of the patients treated with omeprazole.

    View source

    The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia

    Score: 7/10
    2009
    rct
    n=40

    Luthringer R, Muzet M, Zisapel N +1 more

    the PRM group had significantly shorter sleep onset latency (9 min; P = 0.02) compared with the placebo group

    View source

    Meta-analysis: melatonin for the treatment of primary sleep disorders

    Score: 8/10
    2013
    meta_analysis
    n=1683

    Ferracioli-Oda E, et al.

    This meta-analysis demonstrates that melatonin decreases sleep onset latency, increases total sleep time and improves overall sleep quality.

    View source

    Comparative study to determine the optimal melatonin dosage form for the alleviation of jet lag

    Score: 6/10
    1998
    rct
    n=339

    Suhner A, Schlagenhauf P

    Fast-release 5 mg melatonin gave the best subjective jet lag relief among dosage forms tested

    View source

    Melatonin for the prevention and treatment of jet lag

    Score: 9/10
    2002
    meta_analysis

    Herxheimer A, Petrie KJ

    Melatonin taken close to target bedtime decreased jet lag from flights crossing five or more time zones.

    View source

    Effect of exogenous melatonin on endogenous melatonin secretion and circadian phase: a systematic review

    Score: 7/10
    2016
    systematic_review

    Burgess HJ, Emens JS

    Low-dose melatonin taken in the early evening advanced dim light melatonin onset

    View source

    Efficacy and Safety of Melatonin as Prophylaxis for Migraine in Adults: A Meta-analysis

    Score: 6/10
    2022
    meta_analysis

    Puliappadamb HM, Maiti R, Mishra A +1 more

    Melatonin therapy in migraine was associated with a significantly higher responder rate when compared to both placebo and standard therapy (OR = 1.84; 95% CI: 1.08 to 3.14; P = .03).

    View source

    Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects

    Score: 7/10
    2007
    rct
    n=170

    Lemoine P, et al.

    PR-melatonin is the first drug shown to significantly improve quality of sleep and morning alertness in primary insomnia patients aged 55 years and older.

    View source

    Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis

    Score: 9/10
    2006
    meta_analysis

    Buscemi N, Vandermeer B, Hooton N +6 more

    Melatonin did not produce a clinically meaningful reduction in sleep onset latency in secondary sleep disorders or sleep restriction.

    View source

    Effect of melatonin supplementation on sleep quality: a systematic review and meta-analysis of randomized controlled trials

    Score: 8/10
    2022
    meta_analysis

    Fatemeh G, et al.

    We found that the treatment with exogenous melatonin has positive effects on sleep quality as assessed by the Pittsburgh Sleep Quality Index (PSQI) in adult.

    View source

    Is the addition of sublingual melatonin to omeprazole superior to omeprazole alone in the management of gastroesophageal reflux disease symptoms: a clinical trial

    Score: 6/10
    2023
    rct
    n=72

    Malekpour H, et al.

    The combination of sublingual melatonin (3 mg/day) with omeprazole (20 mg/day) may be more effective than omeprazole (20 mg/day) alone in the treatment of gastroesophageal reflux disease.

    View source

    Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes

    Score: 7/10
    2007
    rct
    n=170

    Wade AG, Ford I, Crawford G +4 more

    Prolonged-release melatonin significantly improved sleep quality and morning alertness versus placebo, with no rebound insomnia.

    View source

    Human phase response curves to three days of daily melatonin: 0.5 mg versus 3.0 mg

    Score: 8/10
    2010
    rct

    Burgess HJ, Revell VL, Molina TA +1 more

    Both doses produced comparable circadian phase advances and delays depending on timing relative to circadian phase.

    View source

    Dose finding of melatonin for chronic idiopathic childhood sleep onset insomnia: an RCT

    Score: 8/10
    2010
    rct
    n=72

    van Geijlswijk IM, van der Heijden KB, Egberts ACG +2 more

    All melatonin doses advanced sleep onset and dim light melatonin onset compared with placebo, with no dose-response relationship.

    View source

    Adverse Events Associated with Melatonin for the Treatment of Primary or Secondary Sleep Disorders: A Systematic Review

    Score: 8/10
    2019
    systematic_review

    Besag FMC, Vasey MJ, Lao KSJ +1 more

    Reported adverse events were generally mild and comparable to placebo, most commonly daytime sleepiness, headache, dizziness and nausea.

    View source

    Safety Information

    Potential Side Effects

    Generally safe for short-term use. May cause daytime drowsiness or vivid dreams

    Contraindications

    Autoimmune diseases, seizure disorders, depression

    Drug Interactions

    • Sedatives
    • Blood thinners
    • Diabetes medications
    • Immunosuppressants
    • Birth control

    Pregnancy & Breastfeeding

    Pregnancy: insufficient_data

    Breastfeeding: insufficient_data

    Dosage Guidelines

    Dosage Used in Studies

    0.5-5 mg

    Best Time to Take

    30-60 minutes before bed

    Best Form

    Immediate or sustained-release tablets

    Bioavailability

    Rapid absorption with oral administration. Significant first-pass metabolism. Sustained-release for sleep maintenance vs immediate for sleep onset.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.